biostudies-literatureUnknown9(10)Bellina G<h4>Background</h4>Mitral transcatheter edge-to-edge repair (M-TEER) is commonly performed in elderly patients with severe mitral regurgitation (MR) who are deemed high-risk for surgery. However, its application in younger patients remains limited.<h4>Case summary</h4>We present the case of a 45-year-old male with a history of mitral valve prolapse, who developed severe MR due to chordal rupture. Surgical mitral valve repair was not considered feasible, and the patient successfully underwent M-TEER with implantation of two MitraClips XTW (Abbott Medical, USA), resulting in mild residual regurgitation and a mean mitral valve gradient of 5 mmHg.<h4>Discussion</h4>This case highlights the potential role of M-TEER in selected young patients, expanding its indications beyond traditional cohortsEuropean heart journal. Case reportsytaf464https://www.ebi.ac.uk/biostudies/studies/S-EPMC12495034biostudies-literatureSuccessful mitral-transcatheter edge to edge repair in a young patient with severe primary mitral regurgitation unsuitable for surgery: a case report.PMC12495034Scandura SCapodanno DBellina GGrasso CMazzone PMfalseSuccessful mitral-transcatheter edge to edge repair in a young patient with severe primary mitral regurgitation unsuitable for surgery: a case report.<h4>Background</h4>Mitral transcatheter edge-to-edge repair (M-TEER) is commonly performed in elderly patients with severe mitral regurgitation (MR) who are deemed high-risk for surgery. However, its application in younger patients remains limited.<h4>Case summary</h4>We present the case of a 45-year-old male with a history of mitral valve prolapse, who developed severe MR due to chordal rupture. Surgical mitral valve repair was not considered feasible, and the patient successfully underwent M-TEER with implantation of two MitraClips XTW (Abbott Medical, USA), resulting in mild residual regurgitation and a mean mitral valve gradient of 5 mmHg.<h4>Discussion</h4>This case highlights the potential role of M-TEER in selected young patients, expanding its indications beyond traditional cohorts2025-01-01T00:00:00Z2025 Oct2026-05-31T03:15:13.958Z2026-05-31T03:07:05.561ZS-EPMC124950344105052910.1093/ehjcr/ytaf464